Formerly About Advanced Micro Devices Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Alighieri who wrote (615780)	6/11/2011 2:22:19 PM
From: i-node	Read Replies (2) of 1579893

Klein's article (none of which was original thinking on his part, but most was a regurgitation of a recently released document from "Center on Budget Policies and Priorities". Unfortunately, that report is long on conjecture and short on facts. "Medicare’s trustees, whom you might expect to trumpet their success controlling costs in Part D, are very straightforward about this: “The reduced estimates reflect a higher market penetration of generic drugs and a decline in the number of new drug products that are expected to reach the market during this period.” In other words, old drugs are slipping out of patent and new ones aren’t being invented as quickly as we’d expected, or hoped." Translation: Bring back the f*cking donut hole. The Congressional Budget Office estimated that 93 percent of Medicare enrollees would participate. Instead, 77 percent did. That’s obviously led to lower costs than expected, but not because the program is working better than expected. Klein needs to back this up with a reference. He is misunderstanding what was and was not included in these estimates.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next